黑料网

Genetic kidney disorders; Children; Polycystic kidney disease; Nephronophthisis; Alport syndrome; CAKUT; Diagnosis; Treatment.

Introduction

Genetic disorders of the kidney are a significant cause of chronic kidney disease (CKD) in children, accounting for a substantial proportion of pediatric renal conditions. These disorders often lead to progressive renal dysfunction and can result in end-stage renal disease (ESRD) if not promptly and effectively managed. Early diagnosis and intervention are crucial for improving the long-term outcomes and quality of life for affected children. The advent of molecular genetics has revolutionized the field by enabling the identification of specific genetic mutations responsible for these disorders, facilitating more precise diagnoses and tailored treatment strategies. This article provides an in-depth review of the most prevalent genetic kidney diseases in children, focusing on their genetic underpinnings, clinical manifestations, diagnostic approaches, and current management strategies, highlighting recent advances and future directions in the field. [1]

Polycystic kidney disease

Polycystic Kidney Disease (PKD) is characterized by the development of multiple renal cysts that can lead to end-stage renal disease (ESRD). There are two main forms of PKD: autosomal dominant PKD (ADPKD) and autosomal recessive PKD (ARPKD). ADPKD is more common and usually presents in adulthood, but can occasionally manifest in childhood. ARPKD, on the other hand, typically presents in infancy or early childhood [2].

Nephronophthisis

Nephronophthisis is a ciliopathy that leads to fibrosis and cyst formation at the cortico-medullary junction of the kidneys. It is the most common genetic cause of ESRD in children and is inherited in an autosomal recessive manner. Symptoms include polyuria, polydipsia, and growth retardation, often progressing to renal failure by adolescence [3].

Alport syndrome

Alport syndrome is a genetic disorder affecting the type IV collagen in the glomerular basement membrane, leading to hematuria, progressive renal insufficiency, and sensorineural hearing loss. It can be inherited in X-linked, autosomal recessive, or autosomal dominant patterns. Early diagnosis is crucial for managing renal and extrarenal manifestations [4].

Congenital anomalies of the kidney and urinary tract

CAKUT encompasses a wide range of structural abnormalities of the kidneys and urinary tract, such as renal agenesis, dysplasia, and ureteropelvic junction obstruction. These anomalies can lead to varying degrees of renal dysfunction and are a leading cause of CKD in children. Genetic mutations have been identified in several cases, highlighting the importance of genetic testing in diagnosis [5].

Diagnostic strategies

Diagnosis of genetic kidney disorders in children involves a combination of clinical evaluation, imaging studies, and genetic testing. Ultrasound and MRI are pivotal in identifying structural abnormalities, while genetic testing can confirm the diagnosis by identifying specific mutations. Early diagnosis is essential for monitoring disease progression and implementing timely interventions [6].

Current treatment options

Treatment of genetic kidney disorders in children focuses on managing symptoms and slowing disease progression. This may include antihypertensive therapy, dietary modifications, and renal replacement therapy in advanced cases. Recent advancements in gene therapy and personalized medicine hold promise for more targeted treatments in the future [7].

Description

Genetic disorders of the kidney in children encompass a diverse group of conditions that significantly contribute to Chronic Kidney Disease (CKD) in the pediatric population. These disorders often lead to progressive renal dysfunction and can culminate in End-Stage Renal Disease (ESRD) if not adequately managed. Key conditions include Polycystic Kidney Disease (PKD), nephronophthisis, Alport syndrome, And Congenital Anomalies Of The Kidney and Urinary Tract (CAKUT). Advances in molecular genetics have revolutionized our understanding of these diseases by identifying specific genetic mutations responsible for their pathogenesis. This has enhanced diagnostic accuracy, allowing for early and precise intervention [8]. Clinical manifestations vary widely but typically include symptoms such as hematuria, proteinuria, hypertension, and renal insufficiency. Management strategies are multifaceted, focusing on symptom control, slowing disease progression, and addressing complications. Emerging therapies, including gene therapy and personalized medicine, hold promise for more targeted and effective treatments, offering hope for improved outcomes and quality of life for affected children.

Results

Studies have demonstrated that early intervention and comprehensive management can significantly enhance the quality of life and outcomes for children with genetic kidney disorders. Timely diagnosis allows for prompt treatment, which can slow disease progression, prevent complications, and improve overall health. Comprehensive management, including regular monitoring, medication, dietary adjustments, and, when necessary, renal replacement therapy, is crucial. Genetic counselling plays a vital role by informing families about the nature of the disorder, inheritance patterns, and risks for future offspring. Family screening helps identify asymptomatic carriers or early-stage cases within the family, enabling proactive monitoring and early treatment [9]. This holistic approach not only supports the affected child but also empowers the family with knowledge and resources to manage the condition effectively.

Discussion

The management of genetic kidney disorders in children is particularly challenging due to the wide variability in clinical presentation and the unpredictable nature of disease progression. Each disorder can manifest differently, even among individuals with the same genetic mutation, complicating diagnosis and treatment strategies. Recent advances in genetic research have significantly enhanced our understanding of the underlying mechanisms, enabling more precise and personalized diagnostic and therapeutic approaches. These developments have led to earlier detection and more tailored management plans, improving patient outcomes [10]. However, despite these advances, there remains a critical need for ongoing research to develop curative therapies. Further studies are essential to identify new treatment targets and improve long-term outcomes for children affected by these complex genetic conditions.

Conclusion

Genetic disorders of the kidney in children represent a significant healthcare challenge due to their potential for severe renal impairment and associated complications. Early diagnosis, comprehensive management, and ongoing research are essential to improving outcomes for affected children. Advances in genetic and molecular technologies offer hope for more effective treatments and ultimately, potential cures for these debilitating conditions.

Acknowledgement

None

Conflict of Interest

None

1. Aniebue PN, Onyema GO (2008). Tropical Doctor 38:157-158.

, ,

2. Kenneth E (2010). Social Science Medicine 70: 7–16.

, ,

3. Thabet AM, Thabet SS, Vostanis P (2016). Health Sci J 10: 1.

,

4. Kumar M, Fonagy P (2013). Int Psych 10: 42-45.

, ,

5. Dubois-Comtois K, Bernier A, Tarabulsy GM, Cyr C, St-Laurent D, et al. (2015). Child Abuse Negl 48: 119-130.

, ,

6. Riahi F, Amini F, Salehi Veisi M (2010). Journal of Jahrom University of Medical Sciences 10: 41–46.

,

7. Salmon K, Bryant RA (2002). Clin Psychol Rev 22: 163–188.

, ,

8. Tramontina S, Martins S, Michalowski MB, Ketzer CR, Eizirik M (2001). Can J Psychiatry 46: 941-947.

, ,

9. JDOI DM, Karen (2004). American Sociological Review 69: 636-658.

,

10. Starsburger VC (2002); Newbury Park CA: Sage.